Mortality among a cohort of drug users after their release from prison: An evaluation of the effectiveness of a harm reduction program in Taiwan

Addiction

Volumn 106, Issue 8, 2011, Pages 1437-1445

  Huang, Yen Fang ^a,b   Kuo, Hsu Sung ^a   Lew Ting, Chin Yin ^b   Tian, Fang ^c   Yang, Chin Hui ^a   Tsai, Tzu I ^d   Gange, Stephen J ^c   Nelson, Kenrad E ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cohort study; IDU; Methadone; Mortality; Prisoners; Taiwan

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; AGED; ARTICLE; DRUG USE; EPIDEMIOLOGY; EVALUATION; FEMALE; HARM REDUCTION; HEALTH CARE QUALITY; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; OPIATE SUBSTITUTION TREATMENT; PATIENT; PRISONER; STATISTICS; SUBSTANCE ABUSE; TAIWAN;

ADULT; AGED; DRUG USERS; EPIDEMIOLOGIC METHODS; FEMALE; HARM REDUCTION; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; MORTALITY; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PATIENT DROPOUTS; PRISONERS; PROGRAM EVALUATION; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN; YOUNG ADULT;

EID: 79960249602     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03443.x     Document Type: Article

References (21)

1. Binswanger L. A., Stern M. F., Deyo R. A., Heagerty P. J., Cheadle A., Elmore J. G. etal. Release from prison-a high risk of death for former inmates. N Engl J Med 2007; 356: 157-65.
2. Bird S. M., Hutchinson S. J. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003; 98: 185-90.
3. Farrell M., Marden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008; 103: 251-5.
4. Joukamaa M. The mortality of released Finnish prisoners: a 7 year follow-up study of the WATTU project. Forensic Sci Int 1998; 96: 11-9.
5. Kariminia A., Butler T. G., Corben S. P., Levey M. H., Grant L., Kaldor M. M. etal. Extreme cause-specific mortality in a cohort of adult prisoners-1988 to 2002: a data-linkage study. Int J Epidemiol 2007; 36: 310-6.
6. Seaman S. R., Brettle R. P., Gore S. M. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998; 316: 426-8.
7. Dengenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M. etal. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2010; 106: 32-51.
8. Christensen P. Commentary: extreme cause-specific mortality in a cohort of adult prisoners-1988 to 2002: a data-linkage study. Int J Epidemiol 2007; 36: 317-8.
9. Caplehorn J. R., Drummer O. H. Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med J Aust 1999; 170: 104-9.
10. Esteban J., Gimeno C., Barril J., Aragones A., Climent J. M., de la Cruz Pellin M. etal. Survival study of opioid addicts in relation to their adherence to methadone maintenance treatment. Drug Alcohol Depend 2003; 70: 193-200.
11. Fugelstad A., Rajs J., Bottiger M., Gerhardsson De Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 1995; 90: 711-16.
12. Langendam M., van Brussel G., Coutinho R., van Ameijden E. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health 2001; 91: 774-80.
13. Zanis D. A., Woody G. E. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52: 257-60.
14. Kimber J., Copeland L., Hickman M., Macleod J., McKenzie J., De Angelis D. etal. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 2010; 341: c3172.
15. Buster M. C. A., Brussel G. H. A., Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction 2002; 97: 993-1001.
16. Chen Y. M., Duo S. H. HIV-1 in Taiwan. Lancet 2007; 369: 623-5.
17. Chen Y. M., Lan Y. C., Lai S. F., Yang J. Y., Tsai S. F., Kuo S. H. HIV-1 CRF07-BC infections, injecting drug users, Taiwan. Emerg Infect Dis 2006; 12: 703-5.
18. Lin H. H., Shih Y. L., Liu Y. C., Lee S. S. J., Huang C. K., Chen Y. L. etal. An epidemic of HIV type 1 CRF07-BC infection among injection drug users in Taiwan. J AIDS 2006; 42: 248-55.
19. Lin Y. T., Lan Y. C., Chen Y. J., Huang Y. H., Lee C. M., Liu T. T. etal. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant from 07-BC strains from injection drug users in Taiwan. J Infect Dis 2007; 195: 1283-93.
20. Huang Y., Yang S., Shih L., Liu H., Yang C. An action plan report in Taiwan for the commutated injection drug users released in 2007. 19th International Harm Reduction Conference, Taipeh, Taiwan, 2008.
21. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008; 167: 492-9.